The age of the
mind-machine
is here.
The future of consciousness, tracked daily.
Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.
757+
Companies tracked
across 9 categories
$18B+
VC invested
in the field globally
111+
Articles published
research & industry
Every Sunday
Weekly digest
NeuroTech Digest
"The question is no longer whether machines can think —
but whether they can learn to love."
Browse by category
View all 757 companies →Featured companies
Kernel
Research Tools
Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.
MindMed
Psychedelics
MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.
Recently added
5Blue Software
Neurotechnology ·
ABM Respiratory Care
Neurotechnology ·
Aduro
Neurotechnology ·
Aerska
Neurotechnology ·
AgeneBio
Neurotechnology ·
Funding spotlight
Axon Park
Seed — $6M
Neuros Life Sciences
Series A — $42M
Synaptic Wave Biomedical
Series B — $78M
5Blue Software
Private
ABM Respiratory Care
Private
Aduro
Private
Latest news
A brain-computer device has helped a man regain the ability to speak, according to a new report from the National Institutes of Health.
Tether Evo publishes research addressing long-term implant stability, one of the most critical unsolved challenges in brain-computer interfaces.
A brain implant has restored the sensation of touch in a person with quadriplegia, representing a significant advance in sensory neuroprosthetics.
A Nature-published study shows sensory-guided joint learning dramatically accelerates motor imagery BCI control in untrained users.
ABILITY NeuroTech has begun first-in-human testing of its novel BCI technology, marking a pivotal clinical milestone for the company.
Aurenar has secured $5.7M to advance its neuromodulation device targeting stroke recovery, signaling continued investor confidence in the segment.
Neuvotion announces commercialization of BCI and brain-body interface technologies, backed by a clinical study published in Nature Medicine.
FDA clears Modius Spero via De Novo pathway, marking a significant regulatory milestone for neuromodulation-based PTSD treatment.
Every Sunday
The NeuroTech Digest
Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.
Subscribe free →For companies
Reach neurotech decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →
ResearchNIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
A brain-computer device has helped a man regain the ability to speak, according to a new report from the National Institutes of Health.
2026-08-03
ResearchTether Evo's Breakthrough Research Targets the Durability Problem Holding BCIs Back
Tether Evo publishes research addressing long-term implant stability, one of the most critical unsolved challenges in brain-computer interfaces.
2026-08-02
ResearchBrain Implant Restores Touch Sensation in Person With Quadriplegia, Marking New BCI Milestone
A brain implant has restored the sensation of touch in a person with quadriplegia, representing a significant advance in sensory neuroprosthetics.
2026-08-01
ResearchHuman-Machine Joint Learning Breaks Down the Barrier to Noninvasive BCI Adoption
A Nature-published study shows sensory-guided joint learning dramatically accelerates motor imagery BCI control in untrained users.
2026-07-31
ProductABILITY NeuroTech Reaches First-in-Human Milestone With Novel Brain-Computer Interface
ABILITY NeuroTech has begun first-in-human testing of its novel BCI technology, marking a pivotal clinical milestone for the company.
2026-07-30
FundingAurenar Raises $5.7M to Push Stroke Neuromodulation Device Toward Market
Aurenar has secured $5.7M to advance its neuromodulation device targeting stroke recovery, signaling continued investor confidence in the segment.
2026-07-29
The field, by the numbers
757+
Companies mapped
across 9 sectors
$18B+
VC invested
in the field globally
3×/week
News published
Mon · Wed · Fri
37+
Articles
research & industry
Companies by sector
22
Brain-Computer
12
Cognitive
29
Mental
36
Neuromodulation
32
Neuropharmaceuticals
20
Neurodiagnostics
12
Research
13
Neurofeedback
39
Psychedelics
The NeuroTech Digest
The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.
No spam. Unsubscribe anytime.